India seeks easier pharma access in Brazil, pushes to expand Mercosur trade pact

India seeks predictable regulations and easier market access for its pharmaceutical products. Discussions occurred at the India-Brazil Trade Monitoring Mechanism meeting in Brasilia. Both nations aim to expand the existing India-Mercosur trade agr...

India has urged Brazil to provide a more predictable regulatory environment for pharmaceutical products and ease market-access barriers, as New Delhi looks to expand exports to one of Latin America's largest economies, the commerce ministry said on Monday.

The issue was discussed at the eighth meeting of the India-Brazil Trade Monitoring Mechanism (TMM) held in Brasilia, which was attended by Commerce Secretary Rajesh Agarwal.

Also Read: Brazil pitches greater cooperation in pharma sector with India, eyes production partnership


The two sides made progress towards facilitating greater market access for Indian pharmaceutical products, with India emphasising the need for clearer and more predictable regulatory pathways.

“India emphasised the need for supporting more predictable regulatory pathways and facilitating greater market access,” the commerce ministry said.

India also highlighted its potential role in expanding access to affordable and quality medicines in Brazil, saying greater market access could help strengthen efforts towards more accessible healthcare.
ADVERTISEMENT

The discussions also focused on expanding the existing trade agreement between India and the Mercosur bloc, with both sides agreeing to work towards an early finalisation of the terms of reference for negotiations.

Mercosur comprises Brazil, Argentina, Uruguay and Paraguay.

The India-Mercosur Preferential Trade Agreement (PTA), which came into effect on June 1, 2009, currently provides limited tariff concessions covering 450 products. New Delhi and the South American bloc have been looking to broaden its coverage and eventually move towards a more comprehensive trade agreement.

Also Read: India, Brazil set to seal trade, pharma & minerals pacts during prez Lula's visit; Adani & Embraer deal also on cards
ADVERTISEMENT

“The India-Mercosur Preferential Trade Agreement offers considerable scope for expansion and modernisation. With India-Mercosur bilateral trade reaching USD 20.84 billion in 2025, both sides committed to early finalisation of the Terms of Reference,” the ministry said.

The terms of reference will establish the scope, objectives and negotiating framework for the proposed expansion of the trade pact.
ADVERTISEMENT

Bilateral trade between India and Brazil stood at USD 15.07 billion in 2025-26. The two countries have set a target of raising bilateral trade to USD 30 billion by 2030.

The latest discussions come as India seeks to deepen economic ties with Brazil and expand its presence in the Latin American market, particularly in sectors such as pharmaceuticals, where Indian companies have a significant export footprint.
READ MORE
ADVERTISEMENT

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Industry › Healthcare/Biotech › Pharmaceuticals › India seeks easier pharma access in Brazil, pushes to expand Mercosur trade pact
Text Size:AAA
Success
This article has been saved

*

+